FDA Approves Study of ATS 3f Aortic Bioprosthesis

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced that the FDA has approved a landmark clinical study in which cardiac surgeons will implant the ATS 3f Aortic Bioprosthesis in a younger aortic valve replacement patient population that has not been previously studied in a controlled and scientific manner.
CNBC